Last reviewed · How we verify
KB304
At a glance
| Generic name | KB304 |
|---|---|
| Sponsor | Krystal Biotech, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study Assessing KB304 for the Treatment of Wrinkles in Women (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KB304 CI brief — competitive landscape report
- KB304 updates RSS · CI watch RSS
- Krystal Biotech, Inc. portfolio CI